Compound ID | 522
Synonym(s): MC 207110
Class: Efflux pump inhibitor
| Details of activity: | Permeates bacteria to other antibiotic compounds; effective on MDR pumps |
| Combined with other compounds: | Needs to be coupled with another antibiotic compound |
| Institute where first reported: | Microcide Pharmaceuticals; (Essential Therapeutics (Ceased)); Daiichi Sankyo Pharmaceutical, Japan; Essential Therapeutics (Ceased) |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| Reason Dropped: | Essential Therapeutics closed down in 2004 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/90665180 |
| Citation: |